Pre-order Enquiry
Request Free Sample
Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Research Report 2021
SKU ID : QYR-17230762 | Publishing Date : 18-Jan-2021 | No. of pages : 119
Detailed TOC of Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Research Report 2021
1 B-Cell Chronic Lymphocytic Leukemia Treatment Market Overview1.1 Product Overview and Scope of B-Cell Chronic Lymphocytic Leukemia Treatment
1.2 B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Type
1.2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 AMG-319
1.2.3 ATTCK-20
1.2.4 IDD-002
1.2.5 JNJ-64052781
1.2.6 Lenalidomide
1.2.7 MAT-303
1.2.8 MT-3724
1.2.9 Others
1.3 B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Application
1.3.1 B-Cell Chronic Lymphocytic Leukemia Treatment Sales Comparison by Application: (2021-2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Estimates and Forecasts
1.4.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue 2016-2027
1.4.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales 2016-2027
1.4.3 B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Region: 2016 Versus 2021 Versus 2027
2 B-Cell Chronic Lymphocytic Leukemia Treatment Market Competition by Manufacturers
2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Manufacturers (2016-2021)
2.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Manufacturers (2016-2021)
2.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Average Price by Manufacturers (2016-2021)
2.4 Manufacturers B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturing Sites, Area Served, Product Type
2.5 B-Cell Chronic Lymphocytic Leukemia Treatment Market Competitive Situation and Trends
2.5.1 B-Cell Chronic Lymphocytic Leukemia Treatment Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest B-Cell Chronic Lymphocytic Leukemia Treatment Players Market Share by Revenue
2.5.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 B-Cell Chronic Lymphocytic Leukemia Treatment Retrospective Market Scenario by Region
3.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Country
3.3.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country
3.3.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Country
3.4.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country
3.4.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Region
3.5.1 Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Region
3.5.2 Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Country
3.6.1 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country
3.6.2 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Facts & Figures by Country
3.7.1 Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country
3.7.2 Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global B-Cell Chronic Lymphocytic Leukemia Treatment Historic Market Analysis by Type
4.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2016-2021)
4.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2016-2021)
4.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Price by Type (2016-2021)
5 Global B-Cell Chronic Lymphocytic Leukemia Treatment Historic Market Analysis by Application
5.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application (2016-2021)
5.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Application (2016-2021)
5.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AB Science SA
6.1.1 AB Science SA Corporation Information
6.1.2 AB Science SA Description and Business Overview
6.1.3 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AB Science SA Product Portfolio
6.1.5 AB Science SA Recent Developments/Updates
6.2 Amgen Inc.
6.2.1 Amgen Inc. Corporation Information
6.2.2 Amgen Inc. Description and Business Overview
6.2.3 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Amgen Inc. Product Portfolio
6.2.5 Amgen Inc. Recent Developments/Updates
6.3 Celgene Corporation
6.3.1 Celgene Corporation Corporation Information
6.3.2 Celgene Corporation Description and Business Overview
6.3.3 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Celgene Corporation Product Portfolio
6.3.5 Celgene Corporation Recent Developments/Updates
6.4 Dynavax Technologies Corporation
6.4.1 Dynavax Technologies Corporation Corporation Information
6.4.2 Dynavax Technologies Corporation Description and Business Overview
6.4.3 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Dynavax Technologies Corporation Product Portfolio
6.4.5 Dynavax Technologies Corporation Recent Developments/Updates
6.5 Eisai
6.5.1 Eisai Corporation Information
6.5.2 Eisai Description and Business Overview
6.5.3 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Eisai Product Portfolio
6.5.5 Eisai Recent Developments/Updates
6.6 Elsalys Biotech SAS
6.6.1 Elsalys Biotech SAS Corporation Information
6.6.2 Elsalys Biotech SAS Description and Business Overview
6.6.3 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Elsalys Biotech SAS Product Portfolio
6.6.5 Elsalys Biotech SAS Recent Developments/Updates
6.7 F. Hoffmann-La Roche Ltd.
6.6.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.6.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.6.3 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 F. Hoffmann-La Roche Ltd. Product Portfolio
6.7.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.8 iDD biotech SAS
6.8.1 iDD biotech SAS Corporation Information
6.8.2 iDD biotech SAS Description and Business Overview
6.8.3 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.8.4 iDD biotech SAS Product Portfolio
6.8.5 iDD biotech SAS Recent Developments/Updates
6.9 Immunomedics, Inc.
6.9.1 Immunomedics, Inc. Corporation Information
6.9.2 Immunomedics, Inc. Description and Business Overview
6.9.3 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Immunomedics, Inc. Product Portfolio
6.9.5 Immunomedics, Inc. Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Johnson & Johnson Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 Juno Therapeutics Inc.
6.11.1 Juno Therapeutics Inc. Corporation Information
6.11.2 Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Description and Business Overview
6.11.3 Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Juno Therapeutics Inc. Product Portfolio
6.11.5 Juno Therapeutics Inc. Recent Developments/Updates
6.12 Molecular Templates Inc.
6.12.1 Molecular Templates Inc. Corporation Information
6.12.2 Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Description and Business Overview
6.12.3 Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Molecular Templates Inc. Product Portfolio
6.12.5 Molecular Templates Inc. Recent Developments/Updates
6.13 Noxxon Pharma AG
6.13.1 Noxxon Pharma AG Corporation Information
6.13.2 Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Description and Business Overview
6.13.3 Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Noxxon Pharma AG Product Portfolio
6.13.5 Noxxon Pharma AG Recent Developments/Updates
7 B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturing Cost Analysis
7.1 B-Cell Chronic Lymphocytic Leukemia Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
7.4 B-Cell Chronic Lymphocytic Leukemia Treatment Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 B-Cell Chronic Lymphocytic Leukemia Treatment Distributors List
8.3 B-Cell Chronic Lymphocytic Leukemia Treatment Customers
9 B-Cell Chronic Lymphocytic Leukemia Treatment Market Dynamics
9.1 B-Cell Chronic Lymphocytic Leukemia Treatment Industry Trends
9.2 B-Cell Chronic Lymphocytic Leukemia Treatment Growth Drivers
9.3 B-Cell Chronic Lymphocytic Leukemia Treatment Market Challenges
9.4 B-Cell Chronic Lymphocytic Leukemia Treatment Market Restraints
10 Global Market Forecast
10.1 B-Cell Chronic Lymphocytic Leukemia Treatment Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of B-Cell Chronic Lymphocytic Leukemia Treatment by Type (2022-2027)
10.1.2 Global Forecasted Revenue of B-Cell Chronic Lymphocytic Leukemia Treatment by Type (2022-2027)
10.2 B-Cell Chronic Lymphocytic Leukemia Treatment Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of B-Cell Chronic Lymphocytic Leukemia Treatment by Application (2022-2027)
10.2.2 Global Forecasted Revenue of B-Cell Chronic Lymphocytic Leukemia Treatment by Application (2022-2027)
10.3 B-Cell Chronic Lymphocytic Leukemia Treatment Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of B-Cell Chronic Lymphocytic Leukemia Treatment by Region (2022-2027)
10.3.2 Global Forecasted Revenue of B-Cell Chronic Lymphocytic Leukemia Treatment by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Research Report 2021
List of TablesTable 1. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers B-Cell Chronic Lymphocytic Leukemia Treatment Covered in This Study
Table 5. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Manufacturers (2016-2021)
Table 7. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market B-Cell Chronic Lymphocytic Leukemia Treatment Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturing Sites and Area Served
Table 11. Manufacturers B-Cell Chronic Lymphocytic Leukemia Treatment Product Type
Table 12. Global B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global B-Cell Chronic Lymphocytic Leukemia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Region (2016-2021) & (K Pcs)
Table 16. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Region (2016-2021)
Table 17. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country (2016-2021) & (K Pcs)
Table 19. North America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country (2016-2021)
Table 20. North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country (2016-2021)
Table 22. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country (2016-2021)
Table 24. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Region (2016-2021)
Table 30. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country (2016-2021)
Table 32. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Country (2016-2021)
Table 38. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) by Type (2016-2021)
Table 39. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2016-2021)
Table 40. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million US$) by Type (2016-2021)
Table 41. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Type (2016-2021)
Table 42. Global B-Cell Chronic Lymphocytic Leukemia Treatment Price (USD/Pcs) by Type (2016-2021)
Table 43. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) by Application (2016-2021)
Table 44. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application (2016-2021)
Table 45. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million US$) by Application (2016-2021)
Table 46. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Application (2016-2021)
Table 47. Global B-Cell Chronic Lymphocytic Leukemia Treatment Price (USD/Pcs) by Application (2016-2021)
Table 48. AB Science SA Corporation Information
Table 49. AB Science SA Description and Business Overview
Table 50. AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 52. AB Science SA Recent Developments/Updates
Table 53. Amgen Inc. Corporation Information
Table 54. Amgen Inc. Description and Business Overview
Table 55. Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 57. Amgen Inc. Recent Developments/Updates
Table 58. Celgene Corporation Corporation Information
Table 59. Celgene Corporation Description and Business Overview
Table 60. Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 62. Celgene Corporation Recent Developments/Updates
Table 63. Dynavax Technologies Corporation Corporation Information
Table 64. Dynavax Technologies Corporation Description and Business Overview
Table 65. Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 67. Dynavax Technologies Corporation Recent Developments/Updates
Table 68. Eisai Corporation Information
Table 69. Eisai Description and Business Overview
Table 70. Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 72. Eisai Recent Developments/Updates
Table 73. Elsalys Biotech SAS Corporation Information
Table 74. Elsalys Biotech SAS Description and Business Overview
Table 75. Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 77. Elsalys Biotech SAS Recent Developments/Updates
Table 78. F. Hoffmann-La Roche Ltd. Corporation Information
Table 79. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 80. F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 82. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 83. iDD biotech SAS Corporation Information
Table 84. iDD biotech SAS Description and Business Overview
Table 85. iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 87. iDD biotech SAS Recent Developments/Updates
Table 88. Immunomedics, Inc. Corporation Information
Table 89. Immunomedics, Inc. Description and Business Overview
Table 90. Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 92. Immunomedics, Inc. Recent Developments/Updates
Table 93. Johnson & Johnson Corporation Information
Table 94. Johnson & Johnson Description and Business Overview
Table 95. Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 97. Johnson & Johnson Recent Developments/Updates
Table 98. Juno Therapeutics Inc. Corporation Information
Table 99. Juno Therapeutics Inc. Description and Business Overview
Table 100. Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 102. Juno Therapeutics Inc. Recent Developments/Updates
Table 103. Molecular Templates Inc. Corporation Information
Table 104. Molecular Templates Inc. Description and Business Overview
Table 105. Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 107. Molecular Templates Inc. Recent Developments/Updates
Table 108. Noxxon Pharma AG Corporation Information
Table 109. Noxxon Pharma AG Description and Business Overview
Table 110. Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 112. Noxxon Pharma AG Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. B-Cell Chronic Lymphocytic Leukemia Treatment Distributors List
Table 116. B-Cell Chronic Lymphocytic Leukemia Treatment Customers List
Table 117. B-Cell Chronic Lymphocytic Leukemia Treatment Market Trends
Table 118. B-Cell Chronic Lymphocytic Leukemia Treatment Growth Drivers
Table 119. B-Cell Chronic Lymphocytic Leukemia Treatment Market Restraints
Table 120. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Type (2022-2027) & (K Pcs)
Table 121. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share Forecast by Type (2022-2027)
Table 122. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Application (2022-2027) & (K Pcs)
Table 125. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share Forecast by Application (2022-2027)
Table 126. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Region (2022-2027) & (K Pcs)
Table 129. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share Forecast by Region (2022-2027)
Table 130. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of B-Cell Chronic Lymphocytic Leukemia Treatment
Figure 2. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type in 2020 & 2027
Figure 3. AMG-319 Product Picture
Figure 4. ATTCK-20 Product Picture
Figure 5. IDD-002 Product Picture
Figure 6. JNJ-64052781 Product Picture
Figure 7. Lenalidomide Product Picture
Figure 8. MAT-303 Product Picture
Figure 9. MT-3724 Product Picture
Figure 10. Others Product Picture
Figure 11. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application in 2020 & 2027
Figure 12. Clinic
Figure 13. Hospital
Figure 14. Others
Figure 15. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size 2016-2027 (US$ Million)
Figure 17. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales 2016-2027 (K Pcs)
Figure 18. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 19. B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Manufacturers in 2020
Figure 20. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest B-Cell Chronic Lymphocytic Leukemia Treatment Players: Market Share by Revenue in 2020
Figure 22. B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Region (2016-2021)
Figure 24. Global B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Region in 2020
Figure 25. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Region (2016-2021)
Figure 26. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Region in 2020
Figure 27. U.S. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Taiwan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Philippines B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Vietnam B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Mexico B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Brazil B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Argentina B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. U.A.E B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Type (2016-2021)
Figure 52. Sales Market Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Application (2016-2021)
Figure 53. Sales Market Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Application in 2020
Figure 54. Revenue Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Application (2016-2021)
Figure 55. Revenue Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Application in 2020
Figure 56. Manufacturing Cost Structure of B-Cell Chronic Lymphocytic Leukemia Treatment
Figure 57. Manufacturing Process Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
Figure 58. B-Cell Chronic Lymphocytic Leukemia Treatment Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Keyplayers in Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Research Report 2021
AB Science SAAmgen Inc.
Celgene Corporation
Dynavax Technologies Corporation
Eisai
Elsalys Biotech SAS
F. Hoffmann-La Roche Ltd.
iDD biotech SAS
Immunomedics, Inc.
Johnson & Johnson
Juno Therapeutics Inc.
Molecular Templates Inc.
Noxxon Pharma AG
Request Sample
Request Discount
